Navigation Links
Simbionix and AABIP Sign Collaboration Agreement
Date:11/2/2010

module is being developed in conjunction with, and endorsed by the AABIP. The new module offers designated skill tasks covering the spectrum of Bronchoscopic skills required. This module is intended to provide the trainee with solid habits for safe and efficient performance, and to enhance hand-eye coordination, 3D perception and anatomical knowledge.

Gerard Silvestri, AABIP President, said that "The daily practice of clinicians is highly affected by the progression of medical technologies, as they are required to adapt to fast changes and developments. It is therefore essential to develop new training programs that utilize the advanced technologies, such as virtual reality simulators, to assure that the educational curriculum is entirely covered. We chose to work with simbionix since we believe that only close collaboration between the medical community and companies that provide cutting edge technologies are essential to successfuly design these programs for the benefit of the physicians, the patients and the entire medical field."

"We are very excited to have reached yet another collaboration agreement with a leading medical society" commented Mr. Ran Bronstein, Simbionix President. "All of our products are designed with the cooperation of the medical community, who play an active role in simulation design, content definition, and product testing and validation. Simbionix continuously provides the procedural and technological know-how and actively joins forces with the leading medical associations and the medical industry to optimize training solutions and to advance clinical performance."

About Simbionix USA Corporation

Simbionix is the world's leading provider of simulation and training products for medical professionals and the healthcare industry. Founded in 1997, the company is committed to delivering high quality products, advancing clinical performance and optimizing procedural outcomes.

For more information on Simbi
'/>"/>

SOURCE Simbionix Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
2. Simbionix Introduces the Next Generation in Bronchoscopy Training
3. Simbionix Welcomes Two New Members to Expand Compays Medical Education Product Offerings
4. Simbionix and USF Receive Grant to Support Development of Laparoscopic Hysterectomy Simulation
5. LigoCyte Pharmaceuticals Announces Collaboration With Biogen Idec to Develop Anti-CD103 Therapies
6. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
7. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
8. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
9. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
10. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
11. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... , October 31, 2014 ... clinical-stage pharmaceutical company focused on the development of ... will host a conference call to discuss the ... of ORMD-0801, the company,s proprietary oral insulin capsules, ... 3, 2014 at 10:00 a.m. Eastern time. ...
(Date:10/31/2014)... October 31, 2014 Today, Analysts ... CELG ), Bristol-Myers Squibb Co. (NYSE: ... UNH ), Sanofi SA (NYSE: SNY ) ... these notes ahead of publication. To reserve complementary membership, ... ,-- ,Celgene Corporation Research Reports ,On October 23, 2014, ...
(Date:10/31/2014)... CHICAGO , Oct. 31, 2014  Zacks.com announces the list ... Equity Research analysts discuss the latest news and events impacting stocks ... Amgen (Nasdaq: AMGN - Free Report ), Celgene ... (Nasdaq: BIIB - Free Report ), Market Vectors ... and SPDR S&P Biotech ETF (AMEX: XBI - ...
Breaking Medicine Technology:Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 2Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 3Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 4Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 5Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 6The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 2The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 3The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 4The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 5The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 6The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 7
... and Effective in Patients ... Open-Heart Surgery, WASHINGTON, Sept. 1 Data announced ... very complex coronary,artery disease can safely choose to be ... says The Society for,Cardiovascular Angiography and Interventions (SCAI). The ...
... recent,concern that suicide may be a complication of ... Administration (FDA) approved oral,drug that has been prescribed ... of,asthma and seasonal allergy symptoms. An independent study ... evidence of depression or suicide,linked to montelukast., ...
Cached Medicine Technology:SCAI: SYNTAX Data Show PCI Is a Good Option for Patients With Complex Coronary Artery Disease 2SCAI: SYNTAX Data Show PCI Is a Good Option for Patients With Complex Coronary Artery Disease 3American Lung Association Study Finds No Evidence of Depression or Suicide Linked to Asthma and Allergy Drug Montelukast 2American Lung Association Study Finds No Evidence of Depression or Suicide Linked to Asthma and Allergy Drug Montelukast 3
(Date:10/31/2014)... (PRWEB) October 31, 2014 Daily Gossip writes ... is actually described as the fastest fat loss program ever ... less than a month. , There is no wonder after ... eBook of all time. The new nutrition and workout fat ... and fitness expert. , According to the author of ...
(Date:10/31/2014)... Activz Whole-Food Nutrition is ... line offering natural silver healing support† in liquid supplements, ... silver has been used to support natural healing, and ... the most advanced version available. This latest formula, backed ... that supports the existing healing mechanisms in the human ...
(Date:10/31/2014)... terms of duration of treatment and cost, patients ... accelerated partial breast irradiation (APBI) with proton therapy ... research from The University of Texas MD Anderson ... cost analysis study based on typical patient characteristics, ... charges for eight different types of partial and ...
(Date:10/31/2014)... The Suspension Revolution review published by Daily Gossip ... Dan Long, a suspension training specialist. , Long ... life coach. The author of this program claims that ... impossible , The Suspension Revolution review reveals that this ... efficiency when it comes to burning fat, building muscles, ...
(Date:10/31/2014)... York, NY (PRWEB) October 31, 2014 ... one of the most remarkable gifts of life — ... platform for matching extraordinary surrogate mothers and donors with ... about individuals in unforeseen circumstances. , It’s a collective ... donors, surrogacy agencies, surrogacy lawyers, and fertility clinics that ...
Breaking Medicine News(10 mins):Health News:Xtreme Fat Loss Diet Review Reveals How to Transform Your Body in 25 Days 2Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 2Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 4Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 2Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 3Health News:Suspension Revolution Review Reveals Dan Long's New Suspension Workout Plan 2Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 2Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 3
... WASHINGTON, May 12 Speaker Nancy Pelosi released ... the Social Security and Medicare Trustees, which was released ... of the Social Security and Medicare trust funds. ... left behind a record of recession, deficits and debt, ...
... In a meeting today with President Obama and ... Inc. (REI) drew praise for their innovative employee health ... Association (RILA).Following the meeting, President Obama referred to the ... and Safeway President and CEO Steven Burd, as "some ...
... to hear world voices, especially voices from Africa, about ... , - Dr. Paul Zeitz, GAA executive directorWASHINGTON, May ... than 12,000 health advocates and organizations around the world, ... Zeitz called for a worldwide response to fix ...
... PARS) today reported results for the first quarter ended March ... million, or $0.14 per share, for the first quarter 2009 ... per share, in the first quarter 2008. Cash and short-term ... in net loss for the first quarter 2009 vs. first ...
... Nektar Therapeutics (Nasdaq: NKTR ) is scheduled ... Care Conference in Boston at the Boston InterContinental Hotel on ... will be accessible via a Webcast through a link posted ... website: http://www.nektar.com . This ...
... BurrellesLuce is sponsoring a multifaceted look at "Advanced PR Strategies," one of ... Summit, to take place Sunday, May 17, through Tuesday, May 19, in ... ... BurrellesLuce is sponsoring a multifaceted look at "Advanced PR Strategies," ...
Cached Medicine News:Health News:President Obama Praises Retailers as Part of the Health Care Solution 2Health News:GAA Calls For a Worldwide Response to President Obama's Global Health Budget Shortfalls 2Health News:Pharmos Corporation Reports 2009 First Quarter Results 2Health News:Pharmos Corporation Reports 2009 First Quarter Results 3Health News:Pharmos Corporation Reports 2009 First Quarter Results 4Health News:Pharmos Corporation Reports 2009 First Quarter Results 5Health News:BurrellesLuce Sponsoring Track on 'Advanced PR Strategies' At Annual Industry Summit to Be Held May 17-19 in New York 2Health News:BurrellesLuce Sponsoring Track on 'Advanced PR Strategies' At Annual Industry Summit to Be Held May 17-19 in New York 3
Magniclear is the first presbyopic lens to combine the clear distance optics of a spherical lens, the intermediate visual performance of a multifocal and the predictably crisp, near power of a bifoca...
... is a simultaneous vision lens ... Through a series of front ... LifeStyle Gp delivers up to ... its multi-aspheric center-distance design works ...
Gendron ophthalmic eye surgery stretcher....
... surgical stretcher. M-701 Stretcher has a ... to 32 in., measured with a ... a high range, 28 in. to ... pad can be supplied optionally. Vinyl ...
Medicine Products: